secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001104659-23-115255
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apollo Medical enters $300M term loan facility, $180M funded at close
---------------------------------------------------------------------

- New Term Loan of up to $300M: $180M funded on Nov 3, 2023; $120M delayed draw available for 6 months.
- Matures Nov 3, 2028; amortizes 5%/yr for first 2 years, 7.5% for years 3-4, 10% for year 5.
- Interest at SOFR + 1.50%-2.75% or base rate + 0.50%-1.75%, based on leverage ratio.
- Proceeds used to refinance outstanding revolving loans and for permitted acquisitions and share repurchases.
- Revolving line of credit unchanged at $400M, maturing June 16, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/0001104659-23-115255-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/tm2329882d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-115255

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer